|
 |
European Biopharmaceutical Review
|
| In the search to understand, prevent and treat disease, clinical trials involving healthy volunteers and patients play an essential role. How and why such trials are conducted needs to be understood by the public - as well as by key decision-makers - so that clinical research in the UK receives the focus and attention necessary for it to be successful. Nearly a quarter of the world's top 100 medicines were developed in the UK, making it a leading centre for clinical trials. But clinical studies are increasingly conducted around the world so that greater numbers of patients and different ethnicities can be included in a study. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Professor Trevor Jones, Director General at ABPI
Professor Trevor Jones is Director General of The Association of the British Pharmaceutical Industry, directing all activities relating to the UK pharmaceutical industry, including government relations, on behalf of 80 national and international pharmaceutical companies. From 1987 to 1994, Professor Jones was a main Board Director of Wellcome plc, the UK-based pharmaceuticals company, where he was responsible for R&D, including the development of Zovirax, AZT, Malarone, Lamictal and Tracrium. He was awarded the CBE in the 2003 New Year's Honours List.
|
|
|
|
|
|
 |
Industry Events |
 |
Clinical Trials in Latin America
9-10 September 2010, Lima, Peru
CBI’s Conference on Clinical Trials in Latin America, being held 9–10th September 2010 in Lima, Peru brings together key stakeholders involved with clinical trials in Latin America. Latin America is an increasingly desirable location for running clinical trials, and it is important for those involved to collaborate with colleagues and industry counterparts regarding the challenges of developing, executing and completing clinical trials in Latin America. This is a unique opportunity for pharmaceutical executives in Latin America to hear from key regulatory officials, pharmaceutical leaders, CROs and sites on how all stakeholders in the clinical process can ultimately achieve desired results.
More info >> |
|
 |
News and Press Releases |
 |
Breau Leads Bioanalytical/Analytical Division at MPI Research
MPI Research, the largest single-site preclinical contract research organization worldwide, is pleased to announce that Alan P. Breau, PhD, has joined the company as Vice President of its Bioanalytical and Analytical Services (B/AS) division. B/AS is one of the three core research divisions at MPI Research, along with Drug Safety Evaluation and Discovery Services.
More info >> |
|
  |
